Biosimilar and Biologics Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Biosimilar and Biologics Market

Key Insight

The biosimilar and biologics market was valued at USD 561.7 million in 2025, is projected to reach USD 1,257.3 million by 2036 and is forecast to register a 7.6% CAGR between 2026 and 2036. In 2026, monoclonal antibody holds 32.4% within the drug class segment and bacterial cells represent 45.6% of the source category.

July 15, 2026

Anurag Sharma

250 Pages

Cite this Report

Biosimilar and Biologics Market

https://www.futuremarketinsights.com/reports/biosimilars-and-follow-on-biologics-market

License

Buy Now

Summary ToC Infographics Companies

Infographics

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Biosimilar and Biologics Market

Infographics

Similar Industry Reports